HALEOS LABS LIMITED has informed the Exchange regarding 'Special Window'.
HALEOSLABS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Haleos Labs Limited (formerly SMS Lifesciences India Limited, BSE: 540679, NSE: HALEOSLABS) has informed shareholders about a one-year special window for re-lodging physical share transfer requests. The window runs from February 5, 2026 to February 4, 2027, in line with SEBI circular dated January 30, 2026. It applies only to transfer deeds lodged before April 1, 2019 that were earlier rejected, returned, or left unprocessed due to documentation or procedural issues. All re-lodged transfers will be processed in demat mode only and the shares will be locked in for one year from the date of registration. Shareholders who missed the earlier cutoff of January 6, 2026 are being given this fresh opportunity and can approach the company's Registrar & Transfer Agent, Aarthi Consultants. The company has also reminded shareholders to claim any unclaimed dividends, failing which both the dividend and corresponding shares will be transferred to the Investor Education and Protection Fund Authority (IEPFA) after seven years.
This is a routine regulatory compliance announcement and is unlikely to have any material impact on the stock price. It only benefits shareholders who had earlier failed physical share transfer requests and now wish to complete them in demat form, subject to a one-year lock-in. Retail investors with unclaimed dividends should act quickly to avoid transfer of shares to IEPFA.